197 related articles for article (PubMed ID: 20084460)
1. Storage correction in cells of patients suffering from mucopolysaccharidoses types IIIA and VII after treatment with genistein and other isoflavones.
Arfi A; Richard M; Gandolphe C; Scherman D
J Inherit Metab Dis; 2010 Feb; 33(1):61-7. PubMed ID: 20084460
[TBL] [Abstract][Full Text] [Related]
2. Effects of flavonoids on glycosaminoglycan synthesis: implications for substrate reduction therapy in Sanfilippo disease and other mucopolysaccharidoses.
Kloska A; Jakóbkiewicz-Banecka J; Narajczyk M; Banecka-Majkutewicz Z; Węgrzyn G
Metab Brain Dis; 2011 Mar; 26(1):1-8. PubMed ID: 21305347
[TBL] [Abstract][Full Text] [Related]
3. Secondary storage of dermatan sulfate in Sanfilippo disease.
Lamanna WC; Lawrence R; Sarrazin S; Esko JD
J Biol Chem; 2011 Mar; 286(9):6955-62. PubMed ID: 21193389
[TBL] [Abstract][Full Text] [Related]
4. Glycosaminoglycan levels and structure in a mucopolysaccharidosis IIIA mice and the effect of a highly secreted sulfamidase engineered to cross the blood-brain barrier.
Maccari F; Sorrentino NC; Mantovani V; Galeotti F; Fraldi A; Volpi N
Metab Brain Dis; 2017 Feb; 32(1):203-210. PubMed ID: 27585464
[TBL] [Abstract][Full Text] [Related]
5. High dose genistein aglycone therapy is safe in patients with mucopolysaccharidoses involving the central nervous system.
Kim KH; Dodsworth C; Paras A; Burton BK
Mol Genet Metab; 2013 Aug; 109(4):382-5. PubMed ID: 23845234
[TBL] [Abstract][Full Text] [Related]
6. Genistein-mediated inhibition of glycosaminoglycan synthesis, which corrects storage in cells of patients suffering from mucopolysaccharidoses, acts by influencing an epidermal growth factor-dependent pathway.
Jakóbkiewicz-Banecka J; Piotrowska E; Narajczyk M; Barańska S; Wegrzyn G
J Biomed Sci; 2009 Mar; 16(1):26. PubMed ID: 19272193
[TBL] [Abstract][Full Text] [Related]
7. Genistein reduces lysosomal storage in peripheral tissues of mucopolysaccharide IIIB mice.
Malinowska M; Wilkinson FL; Bennett W; Langford-Smith KJ; O'Leary HA; Jakobkiewicz-Banecka J; Wynn R; Wraith JE; Wegrzyn G; Bigger BW
Mol Genet Metab; 2009 Nov; 98(3):235-42. PubMed ID: 19632871
[TBL] [Abstract][Full Text] [Related]
8. Genistein-mediated inhibition of glycosaminoglycan synthesis as a basis for gene expression-targeted isoflavone therapy for mucopolysaccharidoses.
Piotrowska E; Jakóbkiewicz-Banecka J; Barańska S; Tylki-Szymańska A; Czartoryska B; Wegrzyn A; Wegrzyn G
Eur J Hum Genet; 2006 Jul; 14(7):846-52. PubMed ID: 16670689
[TBL] [Abstract][Full Text] [Related]
9. Genistein increases glycosaminoglycan levels in mucopolysaccharidosis type I cell models.
Kingma SD; Wagemans T; IJlst L; Wijburg FA; van Vlies N
J Inherit Metab Dis; 2014 Sep; 37(5):813-21. PubMed ID: 24699889
[TBL] [Abstract][Full Text] [Related]
10. Murine mucopolysaccharidosis type VII: the impact of therapies on the clinical course and pathology in a murine model of lysosomal storage disease.
Vogler C; Sands MS; Galvin N; Levy B; Thorpe C; Barker J; Sly WS
J Inherit Metab Dis; 1998 Aug; 21(5):575-86. PubMed ID: 9728337
[TBL] [Abstract][Full Text] [Related]
11. Gene expression-targeted isoflavone therapy.
Węgrzyn A
IUBMB Life; 2012 Apr; 64(4):307-15. PubMed ID: 22362546
[TBL] [Abstract][Full Text] [Related]
12. First human treatment with investigational rhGUS enzyme replacement therapy in an advanced stage MPS VII patient.
Fox JE; Volpe L; Bullaro J; Kakkis ED; Sly WS
Mol Genet Metab; 2015 Feb; 114(2):203-8. PubMed ID: 25468648
[TBL] [Abstract][Full Text] [Related]
13. Synthetic genistein derivatives as modulators of glycosaminoglycan storage.
Kloska A; Narajczyk M; Jakóbkiewicz-Banecka J; Grynkiewicz G; Szeja W; Gabig-Cimińska M; Węgrzyn G
J Transl Med; 2012 Jul; 10():153. PubMed ID: 22846663
[TBL] [Abstract][Full Text] [Related]
14. The Role of Dimethyl Sulfoxide (DMSO) in Gene Expression Modulation and Glycosaminoglycan Metabolism in Lysosomal Storage Disorders on an Example of Mucopolysaccharidosis.
Moskot M; Jakóbkiewicz-Banecka J; Kloska A; Piotrowska E; Narajczyk M; Gabig-Cimińska M
Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30646511
[TBL] [Abstract][Full Text] [Related]
15. A new biochemical subtype of the Sanfilippo syndrome: characterization of the storage material in cultured fibroblasts of Sanfilippo C patients.
Kresse H; Von Figura K; Klein U
Eur J Biochem; 1978 Dec; 92(2):333-9. PubMed ID: 153835
[TBL] [Abstract][Full Text] [Related]
16. High dose genistein in Sanfilippo syndrome: A randomised controlled trial.
Ghosh A; Rust S; Langford-Smith K; Weisberg D; Canal M; Breen C; Hepburn M; Tylee K; Vaz FM; Vail A; Wijburg F; O'Leary C; Parker H; Wraith JE; Bigger BW; Jones SA
J Inherit Metab Dis; 2021 Sep; 44(5):1248-1262. PubMed ID: 34047372
[TBL] [Abstract][Full Text] [Related]
17. Heparan sulfate and dermatan sulfate derived disaccharides are sensitive markers for newborn screening for mucopolysaccharidoses types I, II and III.
de Ruijter J; de Ru MH; Wagemans T; Ijlst L; Lund AM; Orchard PJ; Schaefer GB; Wijburg FA; van Vlies N
Mol Genet Metab; 2012 Dec; 107(4):705-10. PubMed ID: 23084433
[TBL] [Abstract][Full Text] [Related]
18. Genistein: a natural isoflavone with a potential for treatment of genetic diseases.
Wegrzyn G; Jakóbkiewicz-Banecka J; Gabig-Cimińska M; Piotrowska E; Narajczyk M; Kloska A; Malinowska M; Dziedzic D; Gołebiewska I; Moskot M; Wegrzyn A
Biochem Soc Trans; 2010 Apr; 38(2):695-701. PubMed ID: 20298245
[TBL] [Abstract][Full Text] [Related]
19. Glycosaminoglycan storage in cultured neonatal murine mucopolysaccharidosis type VII neuroglial cells and correction by beta-glucuronidase gene transfer.
Taylor RM; Wolfe JH
J Neurochem; 1997 May; 68(5):2079-85. PubMed ID: 9109535
[TBL] [Abstract][Full Text] [Related]
20. Recombinant adeno-associated virus-mediated correction of lysosomal storage within the central nervous system of the adult mucopolysaccharidosis type VII mouse.
Sferra TJ; Qu G; McNeely D; Rennard R; Clark KR; Lo WD; Johnson PR
Hum Gene Ther; 2000 Mar; 11(4):507-19. PubMed ID: 10724030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
